Member Info for Ghia

Don't get emotionally attached to shares live to fight another day.

Manipulated yes to suit a larger agenda. They are not manipulated on a whim the manipulation is required to allow larger holders to enter and exit.

The PI often gets caught on the wrong side of this but I'd suggest this is due to inexperience of the PI rather than the key objective of the market maker.

The market maker finds the price point which will enable the volume of trading they require, larger clients will be giving advance notice of the price points they are looking to enter an exit and the market maker can advise on the ability of the market to absorb that volume at that price.

Calm down Jim I suggest you properly look at the trades they are delayed from yesterday and most probably sells.

Thanks Wet I can't see JBER on my level 2 but then I probably haven't subscribed to the full package.

I will see you all next week if I read something of use I will share but i'm going to sit out of these conversations.

Patience will be rewarded. Do and Trust your own research.

I think AZN is the obvious final destination here and I would be very happy with that.

Nice to see it hold on to most of it's gains today, the wider market is looking very grim today.

You only have to look at the companies Twitter account last updated 21 Nov 2018.... to realise the frequency of updates here.

I'm invested in the science and happy to let that do the talking, us PI's can raise the profile by posting factual research and articles as and when they appear.

"15-20 institutions" explains the lack of TR1's I doubt many got close to the 3% required.

Most probably halved their holding around the 75p mark and now have a free ride easy money when you have money.

Deal3r

Sounds like the hospital was not invited to partake in our trial.

The trial has been rolled out to a select few trusts which have specialist expertise in respiratory illnesses. We are undertaking the gold standard of trials and this requires a accurate data collection on a daily basis they have kept the trial to a manageable number of sites for a reason.

The other trial you mentioned sounds like the recovery trial, which we are not part of.

The trial is fully funded and we allowed extra money for manufacturing.

We where also mid COPD trial so we had stock of the drug already.

So unless the statement can be backed up with a source I don’t believe it.

fair few 25k chunks

For anyone interested it was actually Yale not Stamford. I recall finding these lectures interesting many years ago it's a lot of material so might help pass the time before news.

https://oyc.yale.edu/economics/econ-252

I don't see JBER on my book? I have 7 MM's

I used to have a fascinating set of lectures from a professor at Stamford about the psychology of the stock market, it discussed theories on things like gaps, resistance and charts.

I'll see if I can find them/upload them somewhere online well worth a watch.

I understand the frustration creeping in. It is not helped by speculative suggestions such as news this week if it gets said enough people start to expect it.

The company has told us "8 Week trial" and "news in due course".

We are in the final days of week 3!!

News will come and I have every faith people are working around the clock to get this wrapped up as quickly as possible but they will not compromise on accuracy and will not leak partial or unproven information for the benefit of making a quick buck.

So everyone needs to buy in chunks of 700 shares... I'm not sure I buy this but who knows.

Comek2 Just to point out GDR also have a point of care platform. I agree there will be room for multiple suppliers in the testing market.

AVCT are probably uniquely able to cater for the AMAZON delivery type of test, which will be high high volume.

Agreed the longer this stays around the 60p mark the more I am loading up. Sliced a few GDR this am to go in here.

https://twitter.com/NIHRresearch/status/1249666906686095362